US Broker Ratings

West Pharmaceutical Services (WST) Stock Analysis: Exploring a 14% Upside Potential in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a stalwart in the healthcare sector, particularly within the medical instruments and supplies industry. With a robust market capitalization of $21.63 billion,..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a 17.54% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a leader in the healthcare sector, specifically in diagnostics and research, boasts a market capitalization of $21.74 billion. The company is strategically positioned in the..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Unpacking the 46.95% Potential Upside for Investors

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a pioneering force in the biotechnology sector, specializing in the innovative field of ribonucleic acid interference (RNAi) therapeutics. With a substantial market capitalization..

IDEXX Laboratories (IDXX) Stock Analysis: A 29.6% Upside in the Booming Diagnostics Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable force in the healthcare sector, specifically in the diagnostics and research industry. With a market capitalization of $45.06 billion, the company’s..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Unveiling a 16.82% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a pioneering force in the biotechnology sector, is garnering significant attention from investors seeking robust growth and solid financial performance. With its market capitalization standing..

United Therapeutics Corporation (UTHR) Stock Analysis: Evaluating Growth Potential and Analyst Consensus

United Therapeutics Corporation (NASDAQ: UTHR) is a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $24.86 billion, the..

Baxter International (BAX) Stock Analysis: Exploring a 21.78% Potential Upside in Healthcare Innovation

For investors with a keen eye on the healthcare sector, Baxter International Inc. (NYSE: BAX) presents an intriguing opportunity. Despite recent challenges, this established player in the Medical Instruments &..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Unveiling a 42.72% Potential Upside for Investors

For investors seeking opportunities in the healthcare sector, IQVIA Holdings, Inc. (IQV) presents a compelling case. With a market capitalization of $27.24 billion, IQVIA is a prominent player in the..

Abbott Laboratories (ABT) Stock Analysis: Unlocking a 30% Potential Upside for Investors

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector with a formidable presence in the medical devices industry, presents an intriguing opportunity for investors. With a current market capitalization..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Complex Valuations Amid Healthcare Sector Shifts

Investors with a keen eye on the healthcare sector have their sights set on Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry. With a market..

Quest Diagnostics Incorporated (DGX)

⚠️ No article content returned.

..

Elevance Health, Inc. (ELV) Stock Analysis: A Strong Buy with 12% Potential Upside

As investors navigate the ever-evolving healthcare sector, Elevance Health, Inc. (NYSE: ELV) emerges as a noteworthy contender. Formerly known as Anthem, Inc., this Indianapolis-based healthcare giant operates through four key..

STERIS plc (STE) Stock Analysis: Exploring a Potential 25.92% Upside in the Healthcare Sector

STERIS plc (NYSE: STE), a prominent player in the healthcare sector, specializes in providing comprehensive infection prevention products and services. With a market capitalization of $21.77 billion, STERIS operates globally..

Thermo Fisher Scientific Inc (TMO) Investor Outlook: Analyzing the 32.56% Potential Upside

For investors seeking robust opportunities in the healthcare sector, Thermo Fisher Scientific Inc (NYSE: TMO) presents a compelling case with its significant potential upside of 32.56%. With a current market..

Agilent Technologies, Inc. (A): Investor Outlook on Robust Growth Potential and a 39% Upside

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors keen on tapping into robust growth potential...

The Cigna Group (CI) Stock Analysis: Exploring a Potential 22.73% Upside for Investors

The Cigna Group (NYSE: CI), a stalwart in the healthcare sector, continues to stand out with its robust market presence and promising financial metrics. With a market cap of $72.68..

Stryker Corporation (SYK) Stock Analysis: A Promising 27.97% Potential Upside for Healthcare Investors

Stryker Corporation (SYK), a titan in the healthcare sector, specifically within the medical devices industry, stands out in the investment landscape with a market capitalization of $125.43 billion. Headquartered in..

Danaher Corporation (DHR) Stock Analysis: A 41% Upside Potential Awaits Investors

Danaher Corporation (NYSE: DHR), a leading name in the healthcare sector’s diagnostics and research industry, offers investors a promising opportunity with a substantial 41.12% potential upside based on the current..

Becton, Dickinson and Company (BDX) Stock Analysis: Unveiling a 25.85% Potential Upside for Investors

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to command attention from investors with its robust portfolio of medical instruments and supplies. The company, with..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Exploring a 27.39% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a major player in the biotechnology industry, focusing on transformative medicines for serious diseases. With its solid presence in the healthcare sector, Vertex..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds